Company Filing History:
3 out of 1,744 
3 out of 85 
2 out of 5,089 
Years Active: 2010-2019
Title: Inventor Spotlight: Jean-Luc Teillaud from Paris, FR
Introduction
Jean-Luc Teillaud is a notable inventor based in Paris, France. With a remarkable portfolio of five patents, he has made significant contributions to the field of immunology and biochemistry. His innovative work primarily focuses on the production and application of unique antibody formats that have the potential to advance therapeutic options for various diseases.
Latest Patents
Among Jean-Luc Teillaud's latest patents is the invention concerning the "Production of antibody formats and immunological applications of said formats." This patent highlights antibody formats that incorporate VH sequences from Camelidae, such as llamas. His research encompasses antibodies that target anti-CEA or anti-CD16 VH sequences, alongside vectors that express these antibody formats, and methods for their production.
Another significant patent is titled "Antibody method for treatment of a disease in which the target cells are cells which express CD20." This invention presents a method involving a monoclonal antibody targeted against the CD20 antigen, which includes the administration of an anti-CD20 antibody. Notably, the light chains have a specific murine-human chimeric amino acid sequence, and the heavy chains exhibit a distinct chimeric sequence as well.
Career Highlights
Jean-Luc has held pivotal roles at prominent research institutions, including the Institut National de la Santé et de la Recherche Médicale (INSERM) and the Centre National de la Recherche Scientifique (CNRS). His career has been marked by a commitment to advancing medical science through innovative research and development.
Collaborations
Throughout his career, Jean-Luc Teillaud has collaborated with other distinguished professionals, including Christophe De Romeuf and Daniel Baty. These partnerships have not only enriched his research but have also fostered significant advancements in the field of immunology.
Conclusion
Jean-Luc Teillaud exemplifies the spirit of innovation and creativity within the scientific community. His contributions, specifically in the realm of antibody formats and their applications, demonstrate his commitment to improving healthcare outcomes. As he continues to work at the forefront of research, we anticipate further impactful advancements from his endeavors.